191 related articles for article (PubMed ID: 27764808)
21. Acetylation inactivates the transcriptional repressor BCL6.
Bereshchenko OR; Gu W; Dalla-Favera R
Nat Genet; 2002 Dec; 32(4):606-13. PubMed ID: 12402037
[TBL] [Abstract][Full Text] [Related]
22. p53 short peptide (p53pep164) regulates lipopolysaccharide-induced tumor necrosis factor-alpha factor/cytokine expression.
Tang X; Molina M; Amar S
Cancer Res; 2007 Feb; 67(3):1308-16. PubMed ID: 17283168
[TBL] [Abstract][Full Text] [Related]
23. EBNA2 interferes with the germinal center phenotype by downregulating BCL6 and TCL1 in non-Hodgkin's lymphoma cells.
Boccellato F; Anastasiadou E; Rosato P; Kempkes B; Frati L; Faggioni A; Trivedi P
J Virol; 2007 Mar; 81(5):2274-82. PubMed ID: 17151114
[TBL] [Abstract][Full Text] [Related]
24. Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas.
Mestre-Escorihuela C; Rubio-Moscardo F; Richter JA; Siebert R; Climent J; Fresquet V; Beltran E; Agirre X; Marugan I; Marín M; Rosenwald A; Sugimoto KJ; Wheat LM; Karran EL; García JF; Sanchez L; Prosper F; Staudt LM; Pinkel D; Dyer MJ; Martinez-Climent JA
Blood; 2007 Jan; 109(1):271-80. PubMed ID: 16960149
[TBL] [Abstract][Full Text] [Related]
25. Genetic profiling of non-Hodgkin's lymphoma with or without hepatitis C virus infection.
Zekri AR; Ahmed H; Ismail M; El-Nashar AT; El-Mokadem T; Hassan A
Egypt J Immunol; 2010; 17(2):81-90. PubMed ID: 23082489
[TBL] [Abstract][Full Text] [Related]
26. Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells.
Polo JM; Dell'Oso T; Ranuncolo SM; Cerchietti L; Beck D; Da Silva GF; Prive GG; Licht JD; Melnick A
Nat Med; 2004 Dec; 10(12):1329-35. PubMed ID: 15531890
[TBL] [Abstract][Full Text] [Related]
27. Increased expression of the bcl6 and CD10 proteins is associated with increased apoptosis and proliferation in diffuse large B-cell lymphomas.
Bai M; Agnantis NJ; Skyrlas A; Tsanou E; Kamina S; Galani V; Kanavaros P
Mod Pathol; 2003 May; 16(5):471-80. PubMed ID: 12748254
[TBL] [Abstract][Full Text] [Related]
28. Roles of BCL6 in normal and transformed germinal center B cells.
Basso K; Dalla-Favera R
Immunol Rev; 2012 May; 247(1):172-83. PubMed ID: 22500840
[TBL] [Abstract][Full Text] [Related]
29. Influence of Casein kinase II inhibitor CX-4945 on BCL6-mediated apoptotic signaling in B-ALL in vitro and in vivo.
Richter A; Sender S; Lenz A; Schwarz R; Hinz B; Knuebel G; Sekora A; Murua Escobar H; Junghanss C; Roolf C
BMC Cancer; 2020 Mar; 20(1):184. PubMed ID: 32131762
[TBL] [Abstract][Full Text] [Related]
30. miR-10a inhibits cell proliferation and promotes cell apoptosis by targeting BCL6 in diffuse large B-cell lymphoma.
Fan Q; Meng X; Liang H; Zhang H; Liu X; Li L; Li W; Sun W; Zhang H; Zen K; Zhang CY; Zhou Z; Chen X; Ba Y
Protein Cell; 2016 Dec; 7(12):899-912. PubMed ID: 27815824
[TBL] [Abstract][Full Text] [Related]
31. Single nucleotide polymorphism in 5'-flanking region of BCL6 is not associated with increased risk of non-Hodgkin's lymphoma.
Susova S; Trneny M; Soucek P
Cancer Lett; 2006 Jul; 238(1):142-5. PubMed ID: 16125304
[TBL] [Abstract][Full Text] [Related]
32. Small deletions occur in highly conserved regions of the LAZ3/BCL6 major translocation cluster in one case of non-Hodgkin's lymphoma without 3q27 translocation.
Bernardin F; Collyn-d'Hooghe M; Quief S; Bastard C; Leprince D; Kerckaert JP
Oncogene; 1997 Feb; 14(7):849-55. PubMed ID: 9047392
[TBL] [Abstract][Full Text] [Related]
33. Analysis of internal deletions within the BCL6 gene in B-cell non-Hodgkin's lymphoma.
Nakamura Y; Saito K; Furusawa S
Br J Haematol; 1999 Apr; 105(1):274-7. PubMed ID: 10233393
[TBL] [Abstract][Full Text] [Related]
34. Targeted epigenetic repression of a lymphoma oncogene by sequence-specific histone modifiers induces apoptosis in DLBCL.
Luo H; Schmidt JA; Lee YS; Oltz EM; Payton JE
Leuk Lymphoma; 2017 Feb; 58(2):445-456. PubMed ID: 27268204
[TBL] [Abstract][Full Text] [Related]
35. Characterization of t(3;6)(q27;p21) breakpoints in B-cell non-Hodgkin's lymphoma and construction of the histone H4/BCL6 fusion gene, leading to altered expression of Bcl-6.
Kurata M; Maesako Y; Ueda C; Nishikori M; Akasaka T; Uchiyama T; Ohno H
Cancer Res; 2002 Nov; 62(21):6224-30. PubMed ID: 12414651
[TBL] [Abstract][Full Text] [Related]
36. BCL6 controls the expression of the B7-1/CD80 costimulatory receptor in germinal center B cells.
Niu H; Cattoretti G; Dalla-Favera R
J Exp Med; 2003 Jul; 198(2):211-21. PubMed ID: 12860928
[TBL] [Abstract][Full Text] [Related]
37. Identification of heterologous translocation partner genes fused to the BCL6 gene in diffuse large B-cell lymphomas: 5'-RACE and LA - PCR analyses of biopsy samples.
Yoshida S; Kaneita Y; Aoki Y; Seto M; Mori S; Moriyama M
Oncogene; 1999 Dec; 18(56):7994-9. PubMed ID: 10637510
[TBL] [Abstract][Full Text] [Related]
38. Selective targeting of BCL6 induces oncogene addiction switching to BCL2 in B-cell lymphoma.
Dupont T; Yang SN; Patel J; Hatzi K; Malik A; Tam W; Martin P; Leonard J; Melnick A; Cerchietti L
Oncotarget; 2016 Jan; 7(3):3520-32. PubMed ID: 26657288
[TBL] [Abstract][Full Text] [Related]
39. Pathogenetic role of BCL6 translocation in B-cell non-Hodgkin's lymphoma.
Ohno H
Histol Histopathol; 2004 Apr; 19(2):637-50. PubMed ID: 15024721
[TBL] [Abstract][Full Text] [Related]
40. The ITM2B (BRI2) gene is a target of BCL6 repression: Implications for lymphomas and neurodegenerative diseases.
Baron BW; Baron RM; Baron JM
Biochim Biophys Acta; 2015 May; 1852(5):742-8. PubMed ID: 25557390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
